-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
CITIUS ONCOLOGY, INC. quarterly/annual Operating Income (Loss) history and change rate from 2022 to Q2 2025.
- CITIUS ONCOLOGY, INC. Operating Income (Loss) for the quarter ending 30 Jun 2025 was -$4.94M, a 6.83% decline year-over-year.
- CITIUS ONCOLOGY, INC. annual Operating Income (Loss) for 2023 was -$1.01M, a 633% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)